0,932  0,005  Antiinflammatory
0,882  0,007  Apoptosis agonist
0,876  0,003  Nitric oxide antagonist
0,872  0,005  Antileukemic
0,851  0,004  Bone diseases treatment
0,831  0,004  Antipsoriatic
0,812  0,004  Antiosteoporotic
0,768  0,012  CYP3A4 substrate
0,729  0,003  Insulin secretagoues
0,721  0,008  Sensitization
0,696  0,015  Antineoplastic (colorectal cancer)
0,693  0,021  Transcription factor NF kappa B inhibitor
0,683  0,015  Antineoplastic (colon cancer)
0,660  0,006  Antineoplastic (pancreatic cancer)
0,651  0,005  Vascular (periferal) disease treatment
0,581  0,007  Antineoplastic enhancer
0,582  0,038  Antineoplastic (breast cancer)
0,548  0,004  Contraceptive
0,560  0,019  Immunosuppressant
0,555  0,019  Antipruritic, allergic
0,541  0,006  Antineoplastic (liver cancer)
0,548  0,017  Immunomodulator
0,528  0,003  Neurotrophic factor
0,552  0,033  Alzheimer's disease treatment
0,520  0,008  Antineoplastic (lymphocytic leukemia)
0,540  0,039  Antineoplastic (lung cancer)
0,524  0,025  Respiratory analeptic
0,535  0,038  TNF expression inhibitor
0,501  0,005  Antidiabetic (type 1)
0,498  0,005  Antiacne
0,504  0,023  Antineoplastic (melanoma)
0,490  0,019  Antineoplastic (multiple myeloma)
0,474  0,006  Antiparkinsonian, rigidity relieving
0,472  0,006  Prostate disorders treatment
0,465  0,004  Antifungal enhancer
0,485  0,030  CYP2C19 substrate
0,465  0,016  Huntington's disease treatment
0,452  0,011  Calcium channel activator
0,464  0,025  Antineoplastic (glioma)
0,476  0,041  CYP2C9 substrate
0,435  0,007  Antipruritic, non-allergic
0,418  0,006  Sepsis treatment
0,434  0,029  Antioxidant
0,407  0,002  Hypercalcemia treatment
0,416  0,014  Abortion inducer
0,412  0,011  Prostatic (benign) hyperplasia treatment
0,430  0,032  Analeptic
0,410  0,014  Sodium/bile acid cotransporter inhibitor
0,405  0,011  Platelet adhesion inhibitor
0,430  0,038  Antineoplastic (ovarian cancer)
0,410  0,023  Antiparasitic
0,393  0,009  Lipocortins synthesis antagonist
0,410  0,029  Mutagenic
0,415  0,039  Hepatic disorders treatment
0,411  0,036  Radioprotector
0,382  0,012  Interferon gamma antagonist
0,388  0,018  Antihelmintic
0,451  0,083  Caspase 9 stimulant
0,377  0,011  Antialcoholic
0,362  0,004  Farnesoid X receptor antagonist
0,390  0,041  NOS3 expression inhibitor
0,383  0,035  UGT2B4 substrate
0,369  0,021  5 Hydroxytryptamine uptake stimulant
0,399  0,052  Prostate cancer treatment
0,366  0,020  UGT1A4 substrate
0,423  0,078  Cyclophilin D inhibitor
0,423  0,078  Antidiabetic
0,386  0,042  Apoptosis antagonist
0,375  0,037  Cytostatic
0,367  0,033  Antineoplastic (glioblastoma multiforme)
0,371  0,038  NOS2 expression inhibitor
0,345  0,020  Non-steroidal antiinflammatory agent
0,360  0,037  Proliferative diseases treatment
0,351  0,029  Interleukin agonist
0,369  0,048  Teratogen
0,336  0,016  Pneumotoxic
0,355  0,042  Cytotoxic
0,348  0,039  Cardiovascular analeptic
0,360  0,057  ICAM1 expression inhibitor
0,302  0,001  Vitamin D receptor antagonist
0,339  0,038  Antineoplastic (endocrine cancer)
0,319  0,023  UGT2B7 substrate
0,319  0,025  Hepatoprotectant
0,311  0,018  Hair growth stimulant
0,333  0,043  Tumour necrosis factor alpha release inhibitor
0,332  0,043  Free radical scavenger
0,330  0,043  Antineoplastic (lymphoma)
0,328  0,041  Hypolipemic
0,338  0,052  Embryotoxic
0,285  0,002  CYP24 inhibitor
0,320  0,042  Carcinogenic
0,324  0,048  Antipyretic
0,360  0,087  Antiprotozoal
0,300  0,035  UDP-glucuronosyltransferase substrate
0,323  0,061  Lipoprotein disorders treatment
0,291  0,029  VCAM1 expression inhibitor
0,315  0,053  Chemoprotective
0,337  0,079  Antiprotozoal (Plasmodium)
0,261  0,006  Aromatase inhibitor
0,274  0,026  CYP2B6 inhibitor
0,266  0,022  Bone formation stimulant
0,319  0,076  FMO1 substrate
0,335  0,093  GST A substrate
0,309  0,067  5 Hydroxytryptamine release stimulant
0,244  0,009  Contraceptive female
0,237  0,004  Paget's disease treatment
0,252  0,020  UGT2B9 substrate
0,255  0,024  Antiviral (Influenza A)
0,295  0,064  Antihypoxic
0,276  0,046  Chemopreventive
0,242  0,018  Topoisomerase I inhibitor
0,249  0,027  Protein kinase stimulant
0,220  0,004  Hyperparathyroidism treatment
0,279  0,064  GST M1-1 substrate
0,220  0,007  Pregnane X receptor agonist
0,296  0,085  AR expression inhibitor
0,216  0,008  Actinic keratosis treatment
0,223  0,015  Microtubule formation inhibitor
0,270  0,067  Antineoplastic (renal cancer)
0,275  0,084  Cardioprotectant
0,216  0,026  UGT2B10 substrate
0,200  0,010  TRPA1 agonist
0,243  0,054  RNA-directed DNA polymerase inhibitor
0,203  0,015  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,187  0,001  Parathyroid hormone antagonist
0,286  0,100  Cholesterol antagonist
0,190  0,005  Anabolic
0,212  0,031  Uterine stimulant
0,207  0,026  Arachidonic acid antagonist
0,276  0,097  Antineoplastic (brain cancer)
0,248  0,070  Antineoplastic (sarcoma)
0,232  0,054  UGT1A1 substrate
0,247  0,069  DNA synthesis inhibitor
0,272  0,095  Antifungal
0,294  0,120  GABA C receptor rho-3 antagonist
0,189  0,017  Antineoplastic alkaloid
0,208  0,040  Antineoplastic (squamous cell carcinoma)
0,211  0,045  LDLR expression enhancer
0,171  0,006  5-Alpha-reductase inhibitor
0,300  0,136  Antibacterial
0,174  0,011  Keratolytic
0,177  0,020  Vanilloid 1 agonist
0,200  0,044  Antineoplastic (carcinoma)
0,169  0,014  ABCA1 expression enhancer
0,218  0,065  Anesthetic general
0,220  0,074  Antiulcerative
0,189  0,047  UGT2B15 substrate
0,222  0,080  Antihypotensive
0,164  0,023  GABA C receptor antagonist
0,165  0,029  SULT1A1 substrate
0,175  0,043  SULT1A3 substrate
0,204  0,072  Antiviral (Influenza)
0,143  0,014  CDC25A inhibitor
0,167  0,039  Antieczematic
0,166  0,039  Adenylate cyclase stimulant
0,225  0,099  Antiprotozoal (Trypanosoma)
0,219  0,094  Antihypercholesterolemic
0,157  0,033  Menstruation disorders treatment
0,133  0,010  Na+ K+ transporting ATPase inhibitor
0,167  0,046  Alpha-N-acetylglucosaminidase inhibitor
0,228  0,107  Gastrin inhibitor
0,145  0,024  Androgen antagonist
0,175  0,055  Melanin inhibitor
0,139  0,020  UGT2B11 substrate
0,173  0,054  Antiparkinsonian, tremor relieving
0,197  0,079  Neurotrophic factor enhancer
0,128  0,010  Narcotic antagonist
0,129  0,013  Estrogen agonist
0,210  0,094  Antineoplastic (cervical cancer)
0,149  0,033  Choleretic
0,159  0,044  Skin irritative effect
0,123  0,008  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,134  0,020  Inducible nitric-oxide synthase inhibitor
0,152  0,039  Ca2+-transporting ATPase inhibitor
0,203  0,091  UGT1A6 substrate
0,166  0,056  Raynaud's phenomenon treatment
0,203  0,093  Angiogenesis stimulant
0,118  0,009  Estrogen receptor beta agonist
0,258  0,149  Histamine release inhibitor
0,136  0,028  Prolactin inhibitor
0,123  0,017  Bile acid receptor antagonist
0,114  0,011  Androgen agonist
0,165  0,062  Carcinogenic, group 1
0,107  0,005  Anesthetic inhalation
0,130  0,029  GST T1-1 substrate
0,129  0,028  Antispirochetal
0,231  0,130  CTGF expression inhibitor
0,209  0,108  Superoxide dismutase inhibitor
0,140  0,040  Alcohol dehydrogenase substrate
0,112  0,015  Glycine receptor agonist
0,304  0,208  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,229  0,135  Ca(v)3.3 blocker
0,171  0,076  Antineoplastic (bone cancer)
0,100  0,006  Postcoital contraceptive
0,149  0,056  Acetylcholinesterase inhibitor
0,171  0,078  Succinate dehydrogenase inhibitor
0,099  0,011  Glutamate (mGluR6) antagonist
0,096  0,009  Progesterone antagonist
0,149  0,063  CNS active muscle relaxant
0,128  0,042  Estrogen antagonist
0,170  0,085  Antirickettsial
0,160  0,075  UGT1A3 substrate
0,124  0,042  Sulfotransferase substrate
0,114  0,032  Antidote, mercury
0,140  0,059  Antiseptic
0,117  0,036  Estrogen receptor beta antagonist
0,151  0,071  Acaricide
0,143  0,066  Anesthetic
0,132  0,055  Cholesterol synthesis inhibitor
0,105  0,028  Vanilloid agonist
0,083  0,007  Retinoid X alpha receptor agonist
0,085  0,011  Potassium channel Kv1.3 blocker
0,126  0,052  Shock treatment
0,122  0,049  Expectorant
0,074  0,002  Progesterone receptor B antagonist
0,105  0,034  Tocolytic
0,199  0,129  UGT1A9 substrate
0,119  0,049  UGT2B1 substrate
0,096  0,027  SULT1A2 substrate
0,147  0,079  Cholinergic
0,104  0,037  Glutamate release inhibitor
0,086  0,020  Acyl-CoA dehydrogenase inhibitor
0,094  0,033  Estrogen-related receptor beta agonist
0,087  0,026  Anticholelithogenic
0,093  0,033  T cell inhibitor
0,067  0,009  Glucocorticoid antagonist
0,069  0,011  Retinoid X receptor agonist
0,107  0,049  Nitric-oxide synthase inhibitor
0,064  0,006  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,139  0,081  Genotoxic
0,198  0,140  Tyrosine 3 hydroxylase inhibitor
0,141  0,084  Diuretic
0,094  0,038  Glycine receptor antagonist
0,081  0,025  Uterine relaxant
0,115  0,059  Mucolytic
0,123  0,068  Carcinogenic, group 3
0,141  0,087  Eye irritation, high
0,087  0,032  Antidote, organophosphates
0,113  0,059  Ferrochelatase inhibitor
0,077  0,023  Postmenopausal disorders treatment
0,075  0,021  Cannabinoid CB2 receptor antagonist
0,079  0,026  SULT2A1 substrate
0,096  0,043  Contraceptive male
0,059  0,006  Retinoid X receptor antagonist
0,070  0,018  Ryanodine receptor antagonist
0,099  0,047  Antineoplastic antibiotic
0,109  0,058  GABA C receptor agonist
0,098  0,047  Ornithine decarboxylase inhibitor
0,072  0,022  Heme oxygenase stimulant
0,123  0,074  Antismoking
0,053  0,004  Progesterone agonist
0,144  0,096  Muscle relaxant
0,067  0,020  Lysine-specific demethylase 1A inhibitor
0,051  0,005  Retinoid X alpha receptor antagonist
0,191  0,146  Antineoplastic (bladder cancer)
0,088  0,042  Nicotinic alpha4beta2 receptor antagonist
0,056  0,011  Alpha 1L adrenoreceptor agonist
0,101  0,057  Tourette's syndrome treatment
0,048  0,005  Glutamate (mGluR3) agonist
0,149  0,108  Phospholipase C inhibitor
0,091  0,050  Transcription factor NF kappa B stimulant
0,083  0,044  Estrogen receptor alpha antagonist
0,047  0,009  HMG CoA reductase inhibitor
0,050  0,012  Glutamate (mGluR8) agonist
0,093  0,056  Triose-phosphate isomerase inhibitor
0,038  0,001  Vitamin D-like
0,038  0,003  Vitamin D receptor agonist
0,117  0,082  Antihyperlipoproteinemic
0,059  0,027  Nicotinic alpha3beta2 receptor antagonist
0,067  0,035  Antimycoplasmal
0,035  0,004  Retinoid X beta receptor antagonist
0,045  0,015  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,169  0,140  Immunostimulant
0,035  0,007  Retinoid X gamma receptor antagonist
0,077  0,049  Antibiotic
0,036  0,008  5-Alpha-reductase 2 inhibitor
0,048  0,021  Liver X receptor alpha agonist
0,096  0,070  Carcinogenic, group 2B
0,049  0,023  Glutamate (mGluR group III) antagonist
0,124  0,101  Skeletal muscle relaxant
0,044  0,022  Kainate receptor agonist
0,096  0,074  Adenylate kinase inhibitor
0,030  0,010  Vanilloid 2 agonist
0,035  0,016  Liver X receptor beta antagonist
0,223  0,204  CYP2C19 inhibitor
0,136  0,118  Sedative
0,102  0,084  Proteasome inhibitor
0,026  0,009  5-Alpha-reductase 1 inhibitor
0,076  0,059  Acetylcholine nicotinic antagonist
0,029  0,014  Nicotinic acid receptor 2 antagonist
0,108  0,093  Cyclooxygenase 3 inhibitor
0,029  0,015  Hedgehog signaling activator
0,117  0,103  Cell wall synthesis inhibitor
0,031  0,017  Liver X receptor alpha antagonist
0,024  0,011  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,057  0,044  Lipocortins synthesis agonist
0,026  0,013  Retinoid X gamma receptor agonist
0,032  0,020  RNA-directed RNA polymerase stimulant
0,206  0,194  Ulceration
0,035  0,023  Tubulin agonist
0,032  0,021  ATP citrate lysase inhibitor
0,019  0,009  Telomerase stimulant
0,034  0,024  Estrogen receptor alpha agonist
0,044  0,035  Microtubule stabilization
0,037  0,028  Vanilloid 3 antagonist
0,103  0,094  Growth stimulant
0,131  0,122  Movement disorders treatment
0,040  0,031  Cholesterol absorption inhibitor
0,012  0,005  Progesterone receptor A antagonist
0,164  0,157  5 Hydroxytryptamine 3E antagonist
0,022  0,016  Retinoic acid gamma receptor agonist
0,054  0,049  Bombesin 1 receptor agonist
0,039  0,034  Guanylate cyclase inhibitor
0,048  0,043  Aconitate hydratase inhibitor
0,116  0,112  Antidote
0,018  0,014  Methylmalonyl-CoA mutase inhibitor
0,069  0,066  Vanilloid 4 agonist
0,078  0,076  Antineoplastic, alkylator
0,028  0,026  Liver X receptor antagonist
0,085  0,083  Glutathione S-transferase substrate
0,014  0,013  NMDA receptor phencyclidine site antagonist
0,097  0,096  Acetylcholine release stimulant

